Argentarii’s Merck MRK Stock Holding History

Argentarii’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.19M	Buy	9,873 +1,946	+25%	+$225K	0.42%	54
2025 Q4	$834K	Sell	7,927 -1,796	-18%	-$169K	0.27%	80
2025 Q3	$816K	Buy	9,723 +97	+1%	+$7.99K	0.33%	66
2025 Q2	$762K	Buy	9,626 +2,177	+29%	+$173K	0.35%	68
2025 Q1	$669K	Buy	7,449 +3,523	+90%	+$329K	0.33%	80
2024 Q4	$391K	Buy	+3,926	New	+$405K	0.2%	98

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Argentarii's MRK Position: Q1 2026 in Review

Argentarii increased its Merck (MRK) stake by 25% in Q1 2026, buying an estimated $225K and bringing the position to 9,873 shares worth $1.19M. The position accounts for 0.42% of the portfolio, ranked #54.

Argentarii first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Argentarii held 9,873 shares of Merck worth $1.19M as of Q1 2026.
Argentarii bought 1,946 Merck shares in Q1 2026, an estimated $225K.
Merck made up 0.42% of Argentarii's portfolio in Q1 2026, its #54 holding.
Argentarii first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Argentarii's 13F filing for Q1 2026, filed 12 May 2026.